星空游戏网站免费进入|星空彩票电脑版

Abstract

CLC Number:

R967

ZHANG Dan-shen，ZHANG Jian-mei. Methods and Evaluation of Animal Models of Induced Pneumonia[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2019.05.004.

[1] 蔡香菊,马骏,马兰,等.肺炎动物模型复制方法研究进展[J].中兽医医药杂志,2018, 37(02):80-82.
[2] 钟菊迎,崔煦然,崔晓兰,等.金柴抗病毒胶囊对甲型流感病毒H1N1肺炎模型小鼠的保护作用与机制研究[J].中华中医药学刊, 2019: 1-10.
[3] 李美凤,封继宏,魏葆琳.肺炎动物模型研究近况[J].辽宁中医杂志, 2014, 41(03): 601-604.
[4] 王彤,苏鑫,艾新法.肺炎动物模型研究[J].长春中医药大学学报,2018, 34(01): 169-172.
[5] 李斌,朱冬青,于红,等.建立铜绿假单胞菌肺部感染动物模型的两种方法[J].第二军医大学学报,2012, 33(08): 829-832.
[6] Petra J G Zwijnenburg, Tom van der Poll, Sandrine Florqiun, et al. Experimental pneumococcal meningitis in mice: a model of intranasal infection[J].J Infec Dis, 2001, 183(7): 1143-1146.
[7] 胡起波,许忠,高航,等.CRP在小鼠肺炎支原体肺炎模型中的表达及相关机制的研究[J].中国实验诊断学,2014, 18 (2) :183-186.
[8] 孟一鸣,孙文平,杨光,等.自然感染途径建立肺炎链球菌感染性肺炎小鼠模型[J].中国微生态学杂志,2011, 23(11):966-967, 971.
[9] 黎东明,赖天文,邓少嫦,等.恒河猴H5N1禽流感病毒性肺炎模型建立及其发病机制[J].中国人兽共患病学报,2014, 30(08): 806-811.
[10] 黄虎翔,张万明.解淀粉芽孢杆菌致BALB/c小鼠肺炎模型的建立[J].国际呼吸杂志,2015, 35 (21) :1606-1611.
[11] 郭向华,郭润华,宋志军.大鼠慢性绿脓杆菌生物膜肺部感染模型细胞因子水平的变化[J].现代医药卫生,2010, 26(15):2241-2242.
[12] 姚泽忠, 赵振江, 赵瑞斌. 幼龄SD大鼠肺炎克雷伯杆菌肺炎模型的建立及炎症改变的研究[J].皖南医学院学报, 2012, 31 (6) :438-441.
[13] 肖舒心,赵旭,郭蓓宁.采用耳窥镜直视下气管插管法构建小鼠鲍曼不动杆菌肺炎模型[J].中国感染与化疗杂志,2015, 15(01):51-56.
[14] 庄晓亮, 木朝宇, 俞俊岭, 等. HCMV急性间质性肺炎小鼠模型的建立[J].安徽医科大学学报, 2014, 49(09): 1214-1217.
[15] 侯舒,许晓燕,王亚亭.双黄连治疗人巨细胞病毒小鼠肺炎的实验研究[J].安徽医科大学学报,2008(01):62-65.
[16] 张洁旻,张纬建,黄春芳,等.放射性肺损伤小鼠动物模型的建立与鉴定[J].中华肿瘤防治杂志,2009,16(19):1455-1457.
[17] 王策.肺宁颗粒对大鼠放射性肺炎及细胞因子表达的影响[J].中医临床研究,2017, 9(22):21-24.
[18] 陈业民，黄文杰，李胜利，等. 肺炎克雷伯菌致大鼠重症肺炎模型的建立[J]. 第一军医大学学报，2005，25(12)：1498-1502
[19] 邵义祥. 医学实验动物学教程[M]. 南京：东南大学出版社，2003：282-284
[20] Holdsworth R J．Regeneration of the spleen and splenic antotransplantation[J]. Br J Surg, 1991, 78(3): 270
[21] 张均田．现代药理实验方法学[M]．北京：北京医科大学中国协和医科大学联合出版社，1998：1419-1421
[22] 刘晓红，辛德莉，侯安存，等. 小鼠肺炎支原体肺炎模型的建立及干扰素-γ的变化[J]. 中国人兽共患病杂志，2004，20(4)：284-287
[23] Livingstone C D，Levine B A，Sirinek K R. Protection from pulmonary sepsis afforded by splenic autotransplants[J]. Surg Forum, 1992, 33：31
[24] 李继昌，董龙，杨阳. 肺炎支原体感染大鼠实验模型的建立[J]. 畜牧与兽医，2004，36(8)：16-18
[25] 李军，庞龙滨，李哲，等. 经皮气管穿刺法建立家兔白色念珠菌肺炎动物模型[J]. 山东医药，2005，45(4)：23-24
[26] 田曼，李桦，赵德育，等. 呼吸道合胞病毒感染豚鼠动物模型的建立[J]. 江苏医药杂志，2002，28(2)：103
[27] 陈盛霞，陈家旭，徐会娟，等. 卡氏肺孢子虫肺炎大鼠模型的比较研究[J]. 中国人兽共患病杂志，2002，18(1)：79-81
[28] 颜苹苹，严延生，何似. 卡氏肺孢子虫肺炎动物模型的建立及其检测[J]. 疾病控制杂志，2000，4(1)：67-69
[29] 陈锡慰，荣珩. 卡氏肺孢子虫感染小鼠动物模型的研究[J]. 动物学杂志，2001，36(4)：48-50
[30] 倪小毅，陈雅棠. 改良卡氏肺孢子虫肺炎动物模型的建立[J]. 重庆医科大学学报，2000，25(4)：382-384
[31] 李自慧，卢思奇.卡氏肺孢子虫肺炎动物模型及虫体体外培养研究[J]. 中国寄生虫病防治杂志，2004，17(4)：251-253
[32] Salim Merali，Ute Frevert，Jonathan H Williams，et al. Continuous axenic cultivation of Pneumocystis carinii[J]. Proc Natl Acad Sci, 1999, 96(3)：2402-2407
[33] 陆平成,龚婕宁,杨进,等.仙台病毒小鼠肺热证模型的实验研究[J].南京中医药大学学报,1996(03):22-24，64.

Methods and Evaluation of Animal Models of Induced Pneumonia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	WANG Ze-yu, WANG Yu, QIAO Ting-ting, MA Huan, HAO Xiu-qing, ZHENG Mao-Dong, YAN Juan.Analysis and Evaluation of Opioid in the Inpatients During 2021- 2023 in the First Affiliated Hospital of Hebei North University[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 21-.
[2]	SHENG Wen-cai, ZHOU Yue.The Effects of A Combination Therapy of Methylprednisolone and Doxycycline on Inflammatory Factors and Oxidative Stress Indicators in Children with Mycoplasma Pneumoniae Pneumonia[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 37-.
[3]	ZHANG Ao-kai, LI Wen-jie, DONG Yang-yang, CHU Han-bing, DONG Xue-hai, ZHAO Li-yan, ZHANG Wanming , ZHANG Yuan-yuan.Study on Ultra High Performance Liquid Chromatography Fingerprint of Mistletoe[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(3): 1-.
[4]	WANG Bin, XU Jia-yin, LI Ya-di, et al.Internal Quality Control and External Quality Assessment of SAT Test for Mycoplasma Pneumoniae[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(2): 14-.
[5]	ZHAN Xu-li, TANG Jian-hua.Research Progress in Mechanism of Drug Resistance of Carbapenem-Resistant Klebsiella Pneumoniae[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 27-33.
[6]	ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pulmonary Tuberculosis[J]. Acta Neuropharmacologica, 2019, 9(6): 11-14.
[7]	ZHANG Dan-shen1，MA Jia-cheng2.Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, 2019, 9(6): 15-20.
[8]	ZHANG Dan-shen，JIN Shan.Methods and Evaluation of Animal Models of Induced Silicosis[J]. Acta Neuropharmacologica, 2019, 9(6): 21-25.
[9]	ZHANG Dan-shen，WANG Fei-fan.Methods and Evaluation of Animal Models of Induced Pulmonary Edema[J]. Acta Neuropharmacologica, 2019, 9(5): 34-39.
[10]	ZHANG Dan-shen，LI Lan.Methods and Evaluation of Animal Models of Induced Emphysema[J]. Acta Neuropharmacologica, 2019, 9(5): 30-33.
[11]	ZHANG Dan-shen，LI Jia-ying.Methods and Evaluation of Animal Models of Induced Pulmonary Hypertension[J]. Acta Neuropharmacologica, 2019, 9(5): 24-29.
[12]	ZHANG Dan-shen，ZHANG Nan.Methods and Evaluation of Animal Models of Induced Bronchial Asthma[J]. Acta Neuropharmacologica, 2019, 9(4): 1-8.
[13]	SUN Cheng-cheng，LIU Jian-gang，LIU Mei-xia，LI Hao，LUO Zeng-gang.Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models[J]. Acta Neuropharmacologica, 2019, 9(1): 13-17.
[14]	ZHANG Dan-shen，ZHANG Rui-juan.Methods and Evaluation of Animal Models of Induced Acute Respiratory Distress Syndrome[J]. Acta Neuropharmacologica, 2017, 7(6): 7-14.
[15]	CHEN Jian,HOU Hong-wei，LIU Yong，WANG An，HU Qing-yuan.Advances in Research Methods of Blood—Brain Barrier Transporters[J]. Acta Neuropharmacologica, 2016, 6(3): 44-55.